To treat solid tumours, immune checkpoint inhibitors are becoming a popular substitute for cytotoxic chemotherapy. These inhibitors function by reactivating and boosting the body’s T-cell population. While radiotherapy harms cancer cell DNA, chemotherapy directly impacts the growth and multiplication of cancer cells.

Understanding Immune Checkpoint Inhibitors

Immune checkpoint inhibitors are a type of immunotherapy that is becoming increasingly popular in the treatment of certain types of cancer. Unlike traditional therapies such as chemotherapy, these targeted treatments work by harnessing the body’s natural anti-cancer immune response. They boost the immune system’s ability to attack and destroy cancer cells, rather than directly affecting their growth and proliferation.

T-cells are an essential part of our immune system that helps destroy cancer cells. However, some cancer cells produce high levels of proteins that turn T-cells off. Checkpoint inhibitors block this process and reactivate and increase the body’s T-cell population, enhancing the immune system’s ability to recognize and fight cancer cells.

There are different types of immune checkpoint inhibitors, including Ipilimumab, Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, and Durvalumab. These drugs block specific proteins found on T-cells and cancer cells, such as CTLA-4, PD-1, and PD-L1. They are administered by injection or intravenous infusion and can be given as a single-agent treatment or combined with chemotherapy or each other.

However, the mechanism of action of these drugs can result in side effects termed ‘Immune-related adverse events’ that are inflammatory and autoimmune in nature. This is because all immune cells are boosted by these drugs, not just the ones that target cancer. The overactive T-cells can produce side effects such as dry, itchy skin and rashes, nausea and vomiting, decreased appetite, diarrhea, tiredness and fatigue, shortness of breath, and a dry cough. Management of such side effects reflects the inflammatory nature, often involving corticosteroids. It is important to monitor liver, kidney, and thyroid function as these drugs can affect these organs.

In conclusion, the early success of immune checkpoint inhibitors in solid tumors has generated tremendous interest in further developing and exploring these strategies across the oncology disease spectrum. Ongoing testing in clinical trials creates new hope for patients affected by other types of disease.

Abnormalities on FBC and Possible Causes

The FBC shows a normal Hb but an elevated MCV, which could be indicative of alcohol abuse. This is further supported by the patient’s increased confusion and withdrawal, suggesting acute withdrawal. Alcohol is known to cause an increase in MCV, while other causes such as B12 and folate deficiencies would also result in anemia. However, hypothyroidism and hematological malignancies are also associated with high MCV, but they are not likely causes in this clinical picture. Overall, the FBC abnormalities and clinical presentation suggest alcohol abuse and acute withdrawal as the most probable cause.

Transfusion of packed red cells is frequently associated with pyrexia as an adverse event, while infusion of FFP often leads to urticaria as the most common adverse event.

Blood product transfusion complications can be categorized into immunological, infective, and other complications. Immunological complications include acute haemolytic reactions, non-haemolytic febrile reactions, and allergic/anaphylaxis reactions. Infective complications may arise due to transmission of vCJD, although measures have been taken to minimize this risk. Other complications include transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), hyperkalaemia, iron overload, and clotting.

Non-haemolytic febrile reactions are thought to be caused by antibodies reacting with white cell fragments in the blood product and cytokines that have leaked from the blood cell during storage. These reactions may occur in 1-2% of red cell transfusions and 10-30% of platelet transfusions. Minor allergic reactions may also occur due to foreign plasma proteins, while anaphylaxis may be caused by patients with IgA deficiency who have anti-IgA antibodies.

Acute haemolytic transfusion reaction is a serious complication that results from a mismatch of blood group (ABO) which causes massive intravascular haemolysis. Symptoms begin minutes after the transfusion is started and include a fever, abdominal and chest pain, agitation, and hypotension. Treatment should include immediate transfusion termination, generous fluid resuscitation with saline solution, and informing the lab. Complications include disseminated intravascular coagulation and renal failure.

TRALI is a rare but potentially fatal complication of blood transfusion that is characterized by the development of hypoxaemia/acute respiratory distress syndrome within 6 hours of transfusion. On the other hand, TACO is a relatively common reaction due to fluid overload resulting in pulmonary oedema. As well as features of pulmonary oedema, the patient may also be hypertensive, a key difference from patients with TRALI.

Docetaxel, a member of the taxane family, disrupts microtubule function by preventing depolymerisation and disassembly. This reduces free tubulin and halts cell division. Irinotecan inhibits topoisomerase I, preventing relaxation of supercoiled DNA, leading to DNA damage and cell death. Methotrexate inhibits dihydrofolate reductase and thymidylate synthesis, slowing and stopping DNA and protein synthesis necessary for normal cell cycle. Cisplatin binds to DNA, cross-linking and inhibiting replication. Doxorubicin stabilises the topoisomerase II complex, inhibiting DNA and RNA synthesis necessary for cell division.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and potential adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin and anthracyclines, degrade preformed DNA and stabilize DNA-topoisomerase II complex, respectively. However, they can also cause lung fibrosis and cardiomyopathy. Antimetabolites, such as methotrexate and fluorouracil, inhibit dihydrofolate reductase and thymidylate synthesis, respectively. However, they can also cause myelosuppression, mucositis, and liver or lung fibrosis. Drugs that act on microtubules, like vincristine and docetaxel, inhibit the formation of microtubules and prevent microtubule depolymerisation & disassembly, respectively. However, they can also cause peripheral neuropathy, myelosuppression, and paralytic ileus. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I, which prevents relaxation of supercoiled DNA. However, they can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin and hydroxyurea, cause cross-linking in DNA and inhibit ribonucleotide reductase, respectively. However, they can also cause ototoxicity, peripheral neuropathy, hypomagnesaemia, and myelosuppression.

The macroscopic features of this condition typically involve ulcers, fibrosis, and a granulomatous process. It is more commonly a primary occurrence rather than a consequence of acute inflammation.

Chronic inflammation can occur as a result of acute inflammation or as a primary process. There are three main processes that can lead to chronic inflammation: persisting infection with certain organisms, prolonged exposure to non-biodegradable substances, and autoimmune conditions involving antibodies formed against host antigens. Acute inflammation involves changes to existing vascular structure and increased permeability of endothelial cells, as well as infiltration of neutrophils. In contrast, chronic inflammation is characterized by angiogenesis and the predominance of macrophages, plasma cells, and lymphocytes. The process may resolve with suppuration, complete resolution, abscess formation, or progression to chronic inflammation. Healing by fibrosis is the main result of chronic inflammation. Granulomas, which consist of a microscopic aggregation of macrophages, are pathognomonic of chronic inflammation and can be found in conditions such as colonic Crohn’s disease. Growth factors released by activated macrophages, such as interferon and fibroblast growth factor, may have systemic features resulting in systemic symptoms and signs in individuals with long-standing chronic inflammation.

The lymphatic system of the breast is responsible for draining excess fluid and waste products. Lymph from the upper outer quadrant of the breast drains to the axillary lymph nodes, while lymph from the inner quadrants drains to the parasternal lymph nodes. Additionally, some lymph from the lower quadrants drains to the inferior phrenic lymph nodes.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

The diagnosis of multiple myeloma can be supported by the presence of Bence-Jones protein on urinary analysis, although it is not always necessary. This haematological malignancy of plasma cells is characterized by bone pain and lytic bone lesions. Hypercalcaemia can also indicate the presence of multiple myeloma.

Ankylosing spondylitis is a chronic inflammatory arthritis that typically affects young men and is associated with HLA-B27. Symptoms include early-morning back pain that improves with exercise, and an elevated ESR may be observed.

Chronic myeloid leukaemia (CML) is a haematological malignancy that is linked to genetic translocation on chromosome 9 (Philadelphia chromosome). It is characterized by high white cell count, splenomegaly, and blast cells seen on marrow biopsy.

Gastric and pancreatic cancer may present with non-specific symptoms such as fatigue, weight loss, loss of appetite, and abdominal fullness or pain. Biochemistry may be normal or show raised inflammatory markers, and diagnosis is confirmed through biopsy following imaging.

Understanding Multiple Myeloma: Features and Investigations

Multiple myeloma is a type of cancer that affects the plasma cells in the bone marrow. It is most commonly found in patients aged 60-70 years. The disease is characterized by a range of symptoms, which can be remembered using the mnemonic CRABBI. These include hypercalcemia, renal damage, anemia, bleeding, bone lesions, and increased susceptibility to infection. Other features of multiple myeloma include amyloidosis, carpal tunnel syndrome, neuropathy, and hyperviscosity.

To diagnose multiple myeloma, a range of investigations are required. Blood tests can reveal anemia, renal failure, and hypercalcemia. Protein electrophoresis can detect raised levels of monoclonal IgA/IgG proteins in the serum, while bone marrow aspiration can confirm the diagnosis if the number of plasma cells is significantly raised. Imaging studies, such as whole-body MRI or X-rays, can be used to detect osteolytic lesions.

The diagnostic criteria for multiple myeloma require one major and one minor criteria or three minor criteria in an individual who has signs or symptoms of the disease. Major criteria include the presence of plasmacytoma, 30% plasma cells in a bone marrow sample, or elevated levels of M protein in the blood or urine. Minor criteria include 10% to 30% plasma cells in a bone marrow sample, minor elevations in the level of M protein in the blood or urine, osteolytic lesions, or low levels of antibodies in the blood. Understanding the features and investigations of multiple myeloma is crucial for early detection and effective treatment.

The standard chemotherapy regimen for non-Hodgkin lymphoma is R-CHOP, which includes Rituximab (in certain patients), cyclophosphamide, hydroxydaunorubicin, Oncovin (vincristine), and prednisolone. However, one of the significant side effects of vincristine is chemotherapy-induced peripheral neuropathy, which can cause tingling or numbness starting from the extremities. It can also lead to severe neuropathic pain and distal weakness, such as foot drop.

While Rituximab can cause adverse effects such as cardiotoxicity and infections, it is not commonly associated with neurological effects. Cyclophosphamide, on the other hand, can cause chemotherapy-induced nausea and vomiting, bone marrow suppression, and haemorrhagic cystitis due to its toxicity to the bladder epithelium.

Hydroxydaunorubicin is known to cause dilated cardiomyopathy, which can lead to heart failure and has a high mortality rate.

Cytotoxic agents are drugs that are used to kill cancer cells. There are several types of cytotoxic agents, each with their own mechanism of action and potential adverse effects. Alkylating agents, such as cyclophosphamide, work by causing cross-linking in DNA. However, they can also cause haemorrhagic cystitis, myelosuppression, and transitional cell carcinoma. Cytotoxic antibiotics, like bleomycin and anthracyclines, degrade preformed DNA and stabilize DNA-topoisomerase II complex, respectively. However, they can also cause lung fibrosis and cardiomyopathy. Antimetabolites, such as methotrexate and fluorouracil, inhibit dihydrofolate reductase and thymidylate synthesis, respectively. However, they can also cause myelosuppression, mucositis, and liver or lung fibrosis. Drugs that act on microtubules, like vincristine and docetaxel, inhibit the formation of microtubules and prevent microtubule depolymerisation & disassembly, respectively. However, they can also cause peripheral neuropathy, myelosuppression, and paralytic ileus. Topoisomerase inhibitors, like irinotecan, inhibit topoisomerase I, which prevents relaxation of supercoiled DNA. However, they can also cause myelosuppression. Other cytotoxic drugs, such as cisplatin and hydroxyurea, cause cross-linking in DNA and inhibit ribonucleotide reductase, respectively. However, they can also cause ototoxicity, peripheral neuropathy, hypomagnesaemia, and myelosuppression.

The correct diagnosis for the patient is sideroblastic anaemia, which is characterized by hypochromic microcytic anaemia, high levels of ferritin iron and transferrin saturation, and basophilic stippling of red blood cells. This condition is caused by vitamin B6 deficiency due to frequent alcohol consumption, leading to abnormal heme production. The peripheral smear shows basophilic stippling of red blood cells, and there is iron overload causing iron deposition in the bone marrow, observed as increased staining with Prussian blue.

Anaemia of chronic disease, iron deficiency anaemia, and aplastic anaemia are incorrect diagnoses. Anaemia of chronic disease is usually normocytic normochromic and has significantly low levels of folate, B12, and iron while ferritin is high. Iron deficiency anaemia may be microcytic hypochromic, but serum iron, ferritin, and transferrin levels would be reduced. Aplastic anaemia presents with pancytopenia and is rarely found in the given age group.

Understanding Sideroblastic Anaemia

Sideroblastic anaemia is a medical condition that occurs when red blood cells fail to produce enough haem, which is partly synthesized in the mitochondria. This results in the accumulation of iron in the mitochondria, forming a ring around the nucleus known as a ring sideroblast. The condition can be either congenital or acquired.

The congenital cause of sideroblastic anaemia is delta-aminolevulinate synthase-2 deficiency. On the other hand, acquired causes include myelodysplasia, alcohol, lead, and anti-TB medications.

To diagnose sideroblastic anaemia, doctors may conduct a full blood count, iron studies, and a blood film. The results may show hypochromic microcytic anaemia, high ferritin, high iron, high transferrin saturation, and basophilic stippling of red blood cells. A bone marrow test may also be done, and Prussian blue staining can reveal ringed sideroblasts.

Management of sideroblastic anaemia is mainly supportive, and treatment focuses on addressing any underlying cause. Pyridoxine may also be prescribed to help manage the condition.

In summary, sideroblastic anaemia is a condition that affects the production of haem in red blood cells, leading to the accumulation of iron in the mitochondria. It can be congenital or acquired, and diagnosis involves various tests. Treatment is mainly supportive, and addressing any underlying cause is crucial.

The thymus is where T-cells undergo maturation, while they are produced in the bone marrow. Once mature, they can be found in the spleen and lymph nodes where they interact with antigen presenting cells. To investigate the impact of HIV on T-cell maturation, a thymus sample is necessary.

Understanding the Lymphatic System

The lymphatic system is composed of primary and secondary lymphatic organs, as well as lymph vessels. The primary lymphatic organs are the thymus and red bone marrow, which are responsible for the formation and maturation of lymphocytes. These organs contain pluripotent cells that give rise to immunocompetent B cells and pre-T cells. To become mature T cells, pre-T cells must migrate to the thymus.

On the other hand, secondary lymphatic organs include lymph nodes, the spleen, tonsils, mucosa-associated lymphoid tissue (MALT), and Peyer’s patches. These organs filter lymphocytes and activate them to mount an immune response. Understanding the lymphatic system is crucial in comprehending how the body’s immune system works. By knowing the different organs and their functions, we can appreciate how the body fights off infections and diseases.

Metastatic ovarian cancer can be detected in the para-aortic lymph nodes as the ovaries drain to this lymphatic group. This is different from other pelvic organs, which usually drain to the internal and external iliac lymph nodes. The external iliac lymph nodes do not drain the ovary, while the internal iliac lymph nodes do not drain the ovary but drain other pelvic viscera. The deep inguinal lymph nodes drain the clitoris and glans penis, while the superficial inguinal lymph nodes drain the anal canal (below pectinate line), skin below the umbilicus, scrotum, and vulva, but are not significant in the lymphatic drainage of the ovary.

Lymphatic Drainage of Female Reproductive Organs

The lymphatic drainage of the female reproductive organs is a complex system that involves multiple nodal stations. The ovaries drain to the para-aortic lymphatics via the gonadal vessels. The uterine fundus has a lymphatic drainage that runs with the ovarian vessels and may thus drain to the para-aortic nodes. Some drainage may also pass along the round ligament to the inguinal nodes. The body of the uterus drains through lymphatics contained within the broad ligament to the iliac lymph nodes. The cervix drains into three potential nodal stations; laterally through the broad ligament to the external iliac nodes, along the lymphatics of the uterosacral fold to the presacral nodes and posterolaterally along lymphatics lying alongside the uterine vessels to the internal iliac nodes. Understanding the lymphatic drainage of the female reproductive organs is important for the diagnosis and treatment of gynecological cancers.

Von Willebrand’s disease is a genetic cause of coagulation disorders that can result in prolonged bleeding time and nosebleeds. On the other hand, disseminated intravascular coagulation is an acquired condition that does not typically cause increased bleeding time but may occur in patients with sepsis. Acquired hemophilia is also an acquired condition that is not associated with a family history of bleeding disorders. Vitamin K deficiency can lead to increased bleeding time, bruising, and nosebleeds. Reduced liver function can also result in decreased production of clotting factors and an increased risk of bleeding, but this is unlikely to be the cause of the patient’s symptoms based on their medical history.

Understanding Coagulation Disorders

Coagulation disorders refer to conditions that affect the body’s ability to form blood clots. These disorders can be hereditary or acquired. Hereditary coagulation disorders include haemophilia A, haemophilia B, and von Willebrand’s disease. These conditions are caused by genetic mutations that affect the production or function of certain clotting factors in the blood.

On the other hand, acquired coagulation disorders are caused by external factors that affect the body’s ability to form blood clots. These factors include vitamin K deficiency, liver disease, and disseminated intravascular coagulation (DIC). DIC can also cause thrombocytopenia, which is a condition characterized by low platelet counts in the blood. Another acquired coagulation disorder is acquired haemophilia, which is a rare autoimmune disorder that causes the body to produce antibodies that attack clotting factors in the blood.

It is important to understand coagulation disorders as they can lead to serious health complications such as excessive bleeding or blood clots. Treatment for coagulation disorders varies depending on the underlying cause and severity of the condition. It may include medication, blood transfusions, or surgery. Regular monitoring and management of these conditions can help prevent complications and improve quality of life.

The bone marrow in large bones is responsible for the production of human red blood cells through erythropoiesis. Stem cells undergo a 7-day development process to become red blood cells, which then circulate for around 120 days before being eliminated by the spleen. Eryptosis, or programmed red cell death, occurs at the same rate as production.

However, certain diseases can increase the rate of eryptosis, resulting in a shorter lifespan for red blood cells. These diseases include haemolytic uraemic syndrome, sepsis, malaria, sickle cell disease, thalassaemia, iron deficiency, and Wilson’s disease.

Iron deficiency anaemia is a prevalent condition worldwide, with preschool-age children being the most affected. The lack of iron in the body leads to a decrease in red blood cells and haemoglobin, resulting in anaemia. The primary causes of iron deficiency anaemia are excessive blood loss, inadequate dietary intake, poor intestinal absorption, and increased iron requirements. Menorrhagia is the most common cause of blood loss in pre-menopausal women, while gastrointestinal bleeding is the most common cause in men and postmenopausal women. Vegans and vegetarians are more likely to develop iron deficiency anaemia due to the lack of meat in their diet. Coeliac disease and other conditions affecting the small intestine can prevent sufficient iron absorption. Children and pregnant women have increased iron demands, and the latter may experience dilution due to an increase in plasma volume.

The symptoms of iron deficiency anaemia include fatigue, shortness of breath on exertion, palpitations, pallor, nail changes, hair loss, atrophic glossitis, post-cricoid webs, and angular stomatitis. To diagnose iron deficiency anaemia, a full blood count, serum ferritin, total iron-binding capacity, transferrin, and blood film tests are performed. Endoscopy may be necessary to rule out malignancy, especially in males and postmenopausal females with unexplained iron-deficiency anaemia.

The management of iron deficiency anaemia involves identifying and treating the underlying cause. Oral ferrous sulfate is commonly prescribed, and patients should continue taking iron supplements for three months after the iron deficiency has been corrected to replenish iron stores. Iron-rich foods such as dark-green leafy vegetables, meat, and iron-fortified bread can also help. It is crucial to exclude malignancy by taking an adequate history and appropriate investigations if warranted.

The para-aortic nodes are responsible for receiving lymph drainage from the testes. This is because the testes develop in the abdomen and move down the posterior abdominal wall during fetal development, leading to their lymphatic drainage coming from the para-aortic lymph nodes. Therefore, the para-aortic nodes are the most likely location for lymphatic spread from the testes.

The inferior mesenteric nodes are not responsible for lymph drainage from the testes as they primarily drain hindgut structures such as the transverse colon down to the rectum. Similarly, the internal iliac nodes drain the inferior portion of the rectum, the anal canal superior to the pectinate line, and the pelvic viscera, but not the testes. The posterior mediastinal chain is also not responsible for lymph drainage from the testes as it drains the oesophagus, mediastinum, and posterior surface of the diaphragm.

Lymphatic drainage is the process by which lymphatic vessels carry lymph, a clear fluid containing white blood cells, away from tissues and organs and towards lymph nodes. The lymphatic vessels that drain the skin and follow venous drainage are called superficial lymphatic vessels, while those that drain internal organs and structures follow the arteries and are called deep lymphatic vessels. These vessels eventually lead to lymph nodes, which filter and remove harmful substances from the lymph before it is returned to the bloodstream.

The lymphatic system is divided into two main ducts: the right lymphatic duct and the thoracic duct. The right lymphatic duct drains the right side of the head and right arm, while the thoracic duct drains everything else. Both ducts eventually drain into the venous system.

Different areas of the body have specific primary lymph node drainage sites. For example, the superficial inguinal lymph nodes drain the anal canal below the pectinate line, perineum, skin of the thigh, penis, scrotum, and vagina. The deep inguinal lymph nodes drain the glans penis, while the para-aortic lymph nodes drain the testes, ovaries, kidney, and adrenal gland. The axillary lymph nodes drain the lateral breast and upper limb, while the internal iliac lymph nodes drain the anal canal above the pectinate line, lower part of the rectum, and pelvic structures including the cervix and inferior part of the uterus. The superior mesenteric lymph nodes drain the duodenum and jejunum, while the inferior mesenteric lymph nodes drain the descending colon, sigmoid colon, and upper part of the rectum. Finally, the coeliac lymph nodes drain the stomach.

Common lymphoid progenitor cells give rise to NK cells, as well as B-cells and T-cells. The biopsy of the patient in this case reveals Reed-Sternberg cells, indicating Hodgkin’s lymphoma, a cancer of B-cells. Platelets, monocytes, basophils, and erythrocytes, on the other hand, are derived from common myeloid progenitor cells.

Haematopoiesis: The Generation of Immune Cells

Haematopoiesis is the process by which immune cells are produced from haematopoietic stem cells in the bone marrow. These stem cells give rise to two main types of progenitor cells: myeloid and lymphoid progenitor cells. All immune cells are derived from these progenitor cells.

The myeloid progenitor cells generate cells such as macrophages/monocytes, dendritic cells, neutrophils, eosinophils, basophils, and mast cells. On the other hand, lymphoid progenitor cells give rise to T cells, NK cells, B cells, and dendritic cells.

This process is essential for the proper functioning of the immune system. Without haematopoiesis, the body would not be able to produce the necessary immune cells to fight off infections and diseases. Understanding haematopoiesis is crucial in developing treatments for diseases that affect the immune system.

The dimorphic blood film is a rare occurrence that can be seen in only a few medical conditions. One such condition is ACD, which is characterized by disordered iron metabolism, reduced erythropoietin response, and decreased erythropoiesis. However, the exact pathophysiology of ACD is not yet fully understood. In CRF, the problem is compounded by a reduction in EPO production and increased bleeding tendency.

Another cause of a microcytosis disproportionate to the degree of anemia is β-thalassemia trait. This condition is often mistaken for iron deficiency, but it does not respond to iron supplementation. Iron deficiency typically causes a hypochromic, microcytic anemia with some variation in red blood size, but not a dimorphic picture. However, partially treated iron deficiency anemia can lead to a dimorphic blood film.

In summary, the dimorphic blood film is a key feature that can be seen in only a limited number of medical conditions. The underlying causes of this condition is crucial for accurate diagnosis and appropriate treatment.

Transfusion Reactions and the Role of Rh Factor

A transfusion reaction can occur when Rh-positive blood is given to a person who is Rh-negative and has been previously exposed to Rh-positive blood. This exposure can result in the development of anti-Rh antibodies, which can cause a reaction when Rh-positive blood is introduced into the body. In addition to transfusions, the Rh factor can also play a role in pregnancy. If a mother is Rh-negative and the father and baby are Rh-positive, there is a risk of a transfusion reaction occurring in the fetus or newborn, leading to a condition known as hemolytic disease of the fetus and newborn (HDFN). It is important to take preventative measures to avoid transfusion reactions and HDFN, such as ensuring blood compatibility and administering Rh immune globulin to Rh-negative mothers during pregnancy. the role of the Rh factor can help prevent these potentially dangerous reactions.

Understanding Sickle-Cell Anaemia

Sickle-cell anaemia is a genetic disorder that occurs when an abnormal haemoglobin chain, known as HbS, is synthesized due to an autosomal recessive condition. This condition is more common in people of African descent, as the heterozygous condition offers some protection against malaria. In the UK, around 10% of Afro-Caribbean individuals are carriers of HbS. Symptoms in homozygotes typically do not develop until 4-6 months when the abnormal HbSS molecules take over from fetal haemoglobin.

The pathophysiology of sickle-cell anaemia involves the substitution of the polar amino acid glutamate with the non-polar valine in each of the two beta chains (codon 6) of haemoglobin. This substitution decreases the water solubility of deoxy-Hb, causing HbS molecules to polymerize and sickle in the deoxygenated state. HbAS patients sickle at p02 2.5 – 4 kPa, while HbSS patients sickle at p02 5 – 6 kPa. Sickle cells are fragile and can cause haemolysis, block small blood vessels, and lead to infarction.

To diagnose sickle-cell anaemia, haemoglobin electrophoresis is the definitive test. It is essential to understand the pathophysiology and symptoms of sickle-cell anaemia to provide appropriate care and management for affected individuals.

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

The prevention of fibrin degradation is achieved by the inhibition of plasmin through the use of tranexamic acid.

Understanding Tranexamic Acid

Tranexamic acid is a synthetic derivative of lysine that acts as an antifibrinolytic. Its primary function is to bind to lysine receptor sites on plasminogen or plasmin, preventing plasmin from degrading fibrin. This medication is commonly prescribed to treat menorrhagia.

In addition to its use in treating menorrhagia, tranexamic acid has been investigated for its role in trauma. The CRASH 2 trial found that administering tranexamic acid within the first 3 hours of bleeding trauma can be beneficial. In cases of major haemorrhage, tranexamic acid is given as an IV bolus followed by an infusion.

Ongoing research is also exploring the potential of tranexamic acid in treating traumatic brain injury. Overall, tranexamic acid is a medication with important applications in managing bleeding disorders and trauma.

Exposure to nitrosamine increases the likelihood of developing oesophageal and gastric cancer. Nitrosamine is commonly added to processed meats like bacon, ham, sausages, and hot dogs, making frequent consumption of these foods a risk factor for these types of cancer. Nitrosamine is also present in tobacco smoke. On the other hand, flavonoids, which are abundant in plants, have been linked to a decreased risk of gastric cancer. Acrylamide is present in starchy foods, while fluoride is used in water and toothpaste to prevent tooth decay.

Understanding Carcinogens and Their Link to Cancer

Carcinogens are substances that have the potential to cause cancer. These substances can be found in various forms, including chemicals, radiation, and viruses. Aflatoxin, which is produced by Aspergillus, is a carcinogen that can cause liver cancer. Aniline dyes, on the other hand, can lead to bladder cancer, while asbestos is known to cause mesothelioma and bronchial carcinoma. Nitrosamines are another type of carcinogen that can cause oesophageal and gastric cancer, while vinyl chloride can lead to hepatic angiosarcoma.

It is important to understand the link between carcinogens and cancer, as exposure to these substances can increase the risk of developing the disease. By identifying and avoiding potential carcinogens, individuals can take steps to reduce their risk of cancer. Additionally, researchers continue to study the effects of various substances on the body, in order to better understand the mechanisms behind cancer development and to develop new treatments and prevention strategies. With continued research and education, it is possible to reduce the impact of carcinogens on human health.

The Factor V Leiden mutation causes activated protein C resistance, resulting in excess clotting due to inefficient inactivation of factor V. This is the correct answer.

Antiphospholipid antibodies binding to plasma membranes is not the correct answer as it is a mechanism of blood clot formation in antiphospholipid syndrome (APS).

High levels of platelets in the blood is also not the correct answer as it is not implicated in Factor V Leiden. Thrombocytosis, or high levels of platelets, can lead to clots but is not related to this mutation.

Low levels of factor V in the blood is also not the correct answer as factor V deficiency is a rare inherited bleeding disorder, not a clotting disorder. It is a form of haemophilia.

Understanding Factor V Leiden

Factor V Leiden is a common inherited thrombophilia, affecting around 5% of the UK population. It is caused by a mutation in the Factor V Leiden protein, resulting in activated factor V being inactivated 10 times more slowly by activated protein C than normal. This leads to activated protein C resistance, which increases the risk of venous thrombosis. Heterozygotes have a 4-5 fold risk of venous thrombosis, while homozygotes have a 10 fold risk, although the prevalence of homozygotes is much lower at 0.05%.

Despite its prevalence, screening for Factor V Leiden is not recommended, even after a venous thromboembolism. This is because a previous thromboembolism itself is a risk factor for further events, and specific management should be based on this rather than the particular thrombophilia identified.

Other inherited thrombophilias include Prothrombin gene mutation, Protein C deficiency, Protein S deficiency, and Antithrombin III deficiency. The table below shows the prevalence and relative risk of venous thromboembolism for each of these conditions.

Overall, understanding Factor V Leiden and other inherited thrombophilias can help healthcare professionals identify individuals at higher risk of venous thrombosis and provide appropriate management to prevent future events.

Condition | Prevalence | Relative risk of VTE
— | — | —
Factor V Leiden (heterozygous) | 5% | 4
Factor V Leiden (homozygous) | 0.05% | 10
Prothrombin gene mutation (heterozygous) | 1.5% | 3
Protein C deficiency | 0.3% | 10
Protein S deficiency | 0.1% | 5-10
Antithrombin III deficiency | 0.02% | 10-20

Multiple Myeloma and Carpal Tunnel Syndrome

Multiple myeloma (MM) is a condition that results in the increased production of amyloid light chains, which can deposit in various organs, including the narrow carpal tunnel. This deposition can cause carpal tunnel syndrome, which is characterized by median nerve neuropathy. MM is caused by the clonal proliferation of monoclonal antibodies, which can lead to increased plasma volume and free light chains in the blood. These free light chains can then be processed into insoluble fibrillation proteins and deposited in various tissues throughout the body, resulting in amyloid deposits.

It is important to note the ALARM signs and symptoms in the clinical history, such as unexplained weight loss and night sweats, which can indicate malignancy. In this case, MM and prostatic carcinoma are the two most likely options. However, the absence of urinary symptoms in this patient makes MM more likely. It is important to consider that an elderly gentleman presenting with low back pain could suggest secondary metastases to axial vertebral bone from primary prostatic carcinoma and should be high up on the list of differentials.

In summary, carpal tunnel syndrome can be a result of amyloid deposition in the carpal tunnel due to MM. It is important to consider the ALARM signs and symptoms in the clinical history to determine the likelihood of malignancy, and to consider other potential causes of symptoms such as vertebral compression fracture.

Lead poisoning can cause the accumulation of lead in the metaphysis of bones, which can be seen as bands of increased density on x-rays. In this case, the child’s recent deterioration in academic and physical performance, along with the history of moving to an old house, suggests the possibility of lead-based paint exposure. The presence of a lead line on the gums further supports this suspicion. While normocytic anemia can have many causes, the addition of radiodense lines in the metaphysis of long bones increases the likelihood of lead poisoning. Cretinism, caused by maternal hypothyroidism, typically presents earlier and has different symptoms. Osteomyelitis, an infection of the bone, has different x-ray findings. Sickle cell anemia and iron deficiency are not associated with the symptoms and x-ray findings in this case.

Lead poisoning is a condition that should be considered when a patient presents with abdominal pain and neurological symptoms, along with acute intermittent porphyria. This condition is caused by defective ferrochelatase and ALA dehydratase function. Symptoms of lead poisoning include abdominal pain, peripheral neuropathy (mainly motor), neuropsychiatric features, fatigue, constipation, and blue lines on the gum margin (which is rare in children and only present in 20% of adult patients).

To diagnose lead poisoning, doctors typically measure the patient’s blood lead level, with levels greater than 10 mcg/dl considered significant. A full blood count may also be performed, which can reveal microcytic anemia and red cell abnormalities such as basophilic stippling and clover-leaf morphology. Additionally, raised serum and urine levels of delta aminolaevulinic acid may be seen, which can sometimes make it difficult to differentiate from acute intermittent porphyria. Urinary coproporphyrin is also increased, while urinary porphobilinogen and uroporphyrin levels are normal to slightly increased. In children, lead can accumulate in the metaphysis of the bones, although x-rays are not typically part of the standard work-up.

Various chelating agents are currently used to manage lead poisoning, including dimercaptosuccinic acid (DMSA), D-penicillamine, EDTA, and dimercaprol. These agents work to remove the lead from the body and can help alleviate symptoms.

The submental lymph nodes are the primary site of lymphatic drainage from the tip of the tongue. The lymph will then spread to the deep cervical lymph nodes.

Lymphatic Drainage of the Tongue

The lymphatic drainage of the tongue varies depending on the location of the tumour. The anterior two-thirds of the tongue have minimal communication of lymphatics across the midline, resulting in metastasis to the ipsilateral nodes being more common. On the other hand, the posterior third of the tongue has communicating networks, leading to early bilateral nodal metastases being more common in this area.

The tip of the tongue drains to the submental nodes and then to the deep cervical nodes, while the mid portion of the tongue drains to the submandibular nodes and then to the deep cervical nodes. If mid tongue tumours are laterally located, they will usually drain to the ipsilateral deep cervical nodes. However, those from more central regions may have bilateral deep cervical nodal involvement. Understanding the lymphatic drainage of the tongue is crucial in determining the spread of tumours and planning appropriate treatment.

Schistocytes on a blood film are indicative of intravascular haemolysis, which is the most likely cause in this clinical scenario. The presence of a mid-line sternotomy scar, metallic click to the first heart sound, and warfarin prescription suggests a metal heart valve, which can cause sheering of red blood cells and subsequent intravascular haemolysis. Vasculitis, thrombotic thrombocytopenic purpura (TTP), and B12 deficiency are less likely causes in this case.

Pathological Red Cell Forms in Blood Films

Blood films are used to examine the morphology of red blood cells and identify any abnormalities. Pathological red cell forms are associated with various conditions and can provide important diagnostic information. Some of the common pathological red cell forms include target cells, tear-drop poikilocytes, spherocytes, basophilic stippling, Howell-Jolly bodies, Heinz bodies, schistocytes, pencil poikilocytes, burr cells (echinocytes), and acanthocytes.

Target cells are seen in conditions such as sickle-cell/thalassaemia, iron-deficiency anaemia, hyposplenism, and liver disease. Tear-drop poikilocytes are associated with myelofibrosis, while spherocytes are seen in hereditary spherocytosis and autoimmune hemolytic anaemia. Basophilic stippling is a characteristic feature of lead poisoning, thalassaemia, sideroblastic anaemia, and myelodysplasia. Howell-Jolly bodies are seen in hyposplenism, while Heinz bodies are associated with G6PD deficiency and alpha-thalassaemia. Schistocytes or ‘helmet cells’ are seen in conditions such as intravascular haemolysis, mechanical heart valve, and disseminated intravascular coagulation. Pencil poikilocytes are seen in iron deficiency anaemia, while burr cells (echinocytes) are associated with uraemia and pyruvate kinase deficiency. Acanthocytes are seen in abetalipoproteinemia.

In addition to these red cell forms, hypersegmented neutrophils are seen in megaloblastic anaemia. Identifying these pathological red cell forms in blood films can aid in the diagnosis and management of various conditions.

If a patient has a history of gastrectomy and is experiencing macrocytic anaemia, it is likely that they are suffering from B12 deficiency.

Vitamin B12 is essential for the development of red blood cells and the maintenance of the nervous system. It is absorbed through the binding of intrinsic factor, which is secreted by parietal cells in the stomach, and actively absorbed in the terminal ileum. A deficiency in vitamin B12 can be caused by pernicious anaemia, post gastrectomy, a vegan or poor diet, disorders or surgery of the terminal ileum, Crohn’s disease, or metformin use.

Symptoms of vitamin B12 deficiency include macrocytic anaemia, a sore tongue and mouth, neurological symptoms, and neuropsychiatric symptoms such as mood disturbances. The dorsal column is usually affected first, leading to joint position and vibration issues before distal paraesthesia.

Management of vitamin B12 deficiency involves administering 1 mg of IM hydroxocobalamin three times a week for two weeks, followed by once every three months if there is no neurological involvement. If a patient is also deficient in folic acid, it is important to treat the B12 deficiency first to avoid subacute combined degeneration of the cord.

The primary route of coagulation is the extrinsic pathway, which is inhibited by heparin’s ability to prevent the activation of factors 2, 9, 10, and 11. The convergence of both pathways occurs during the activation of factor 10. Fibrinogen is transformed into fibrin by thrombin. Plasminogen is converted to plasmin during fibrinolysis, which breaks down fibrin.

The Coagulation Cascade: Two Pathways to Fibrin Formation

The coagulation cascade is a complex process that leads to the formation of a blood clot. There are two pathways that can lead to fibrin formation: the intrinsic pathway and the extrinsic pathway. The intrinsic pathway involves components that are already present in the blood and has a minor role in clotting. It is initiated by subendothelial damage, such as collagen, which leads to the formation of the primary complex on collagen by high-molecular-weight kininogen (HMWK), prekallikrein, and Factor 12. This complex activates Factor 11, which in turn activates Factor 9. Factor 9, along with its co-factor Factor 8a, forms the tenase complex, which activates Factor 10.

The extrinsic pathway, on the other hand, requires tissue factor released by damaged tissue. This pathway is initiated by tissue damage, which leads to the binding of Factor 7 to tissue factor. This complex activates Factor 9, which works with Factor 8 to activate Factor 10. Both pathways converge at the common pathway, where activated Factor 10 causes the conversion of prothrombin to thrombin. Thrombin hydrolyses fibrinogen peptide bonds to form fibrin and also activates factor 8 to form links between fibrin molecules.

Finally, fibrinolysis occurs, which is the process of clot resorption. Plasminogen is converted to plasmin to facilitate this process. It is important to note that certain factors are involved in both pathways, such as Factor 10, and that some factors are vitamin K dependent, such as Factors 2, 7, 9, and 10. The intrinsic pathway can be assessed by measuring the activated partial thromboplastin time (APTT), while the extrinsic pathway can be assessed by measuring the prothrombin time (PT).

Genetics of Haematological Malignancies

Haematological malignancies are cancers that affect the blood, bone marrow, and lymphatic system. These cancers are often associated with specific genetic abnormalities, such as translocations. Here are some common translocations and their associated haematological malignancies:

– Philadelphia chromosome (t(9;22)): This translocation is present in more than 95% of patients with chronic myeloid leukaemia (CML). It results in the fusion of the Abelson proto-oncogene with the BCR gene on chromosome 22, creating the BCR-ABL gene. This gene codes for a fusion protein with excessive tyrosine kinase activity, which is a poor prognostic indicator in acute lymphoblastic leukaemia (ALL).

– t(15;17): This translocation is seen in acute promyelocytic leukaemia (M3) and involves the fusion of the PML and RAR-alpha genes.

– t(8;14): Burkitt’s lymphoma is associated with this translocation, which involves the translocation of the MYC oncogene to an immunoglobulin gene.

– t(11;14): Mantle cell lymphoma is associated with the deregulation of the cyclin D1 (BCL-1) gene.

– t(14;18): Follicular lymphoma is associated with increased BCL-2 transcription due to this translocation.

Understanding the genetic abnormalities associated with haematological malignancies is important for diagnosis, prognosis, and treatment.

Rivaroxaban is a direct inhibitor of factor Xa, which is the correct answer. Pulmonary emboli can be caused by various factors, and symptoms include chest pain, dyspnoea, and haemoptysis. Factor Xa inhibitors, such as rivaroxaban, have replaced warfarin as the first-line treatment for stroke prevention in patients with atrial fibrillation.

Dabigatran is a direct thrombin inhibitor and has a different mechanism of action compared to rivaroxaban. It is commonly used for venous thromboembolism prophylaxis after total knee or hip replacement surgery.

Dalteparin is a type of low molecular weight heparin (LMWH) and has a different mechanism of action compared to factor Xa inhibitors. It is used for prophylaxis against venous thromboembolism in patients who are immobile or have recently had surgery.

Fondaparinux is an indirect inhibitor of factor Xa and is not the correct answer. It is used for the treatment of deep-vein thrombosis, pulmonary embolism, and acute coronary syndrome.

Direct oral anticoagulants (DOACs) are medications used to prevent stroke in non-valvular atrial fibrillation (AF), as well as for the prevention and treatment of venous thromboembolism (VTE). To be prescribed DOACs for stroke prevention, patients must have certain risk factors, such as a prior stroke or transient ischaemic attack, age 75 or older, hypertension, diabetes mellitus, or heart failure. There are four DOACs available, each with a different mechanism of action and method of excretion. Dabigatran is a direct thrombin inhibitor, while rivaroxaban, apixaban, and edoxaban are direct factor Xa inhibitors. The majority of DOACs are excreted either through the kidneys or the liver, with the exception of apixaban and edoxaban, which are excreted through the feces. Reversal agents are available for dabigatran and rivaroxaban, but not for apixaban or edoxaban.